The Nanfang clinic in China's
southern Guangdong province says it offers Chinese patients seeking in-vitro
fertilization (IVF) the chance to choose the gender of their child, avoid
stringent approval checks and snarling queues.
It has to advertise this with
caution. China's strict regulation of its IVF market forbids gender selection,
requires birth licences and proof of marriage, and prohibits some more advanced
procedures - rules that have pushed patients to go overseas or seek treatment
in unregulated clinics at home.
Demand for IVF in China is expected
to rise after Beijing scrapped its controversial one-child policy in October,
which will strain already-crowded state-run hospitals but create opportunities for overseas
health centres, firms helping train local doctors - and underground clinics.
"Here we can do IVF with gender
selection and you don't need lots of documentation," a doctor at the
Guangdong clinic surnamed Hao told Reuters, adding there had been a 50 percent
jump in consultations since the one-child policy announcement.
She said many of her patients were younger
women opting for IVF so they could choose a boy, a traditional preference. The
doctor did not give her full name and "Nanfang" is a common name for
businesses in southern China.
Beijing's tight control makes it hard
for private firms to operate IVF clinics in the country, but growing demand for
doctors and specialists has created other gaps in the market.
Miyabaobei: End of
China's one-child policy is positive
Wei Sun, CFO
of Chinese e-commerce platform Miyabaobei, says Beijing's decision to
scrap its one-child policy will fuel the consumption power of China's
middle class.
"Training to help up-skill
clinicians and embryologists to treat the patients is definitely a big growth
area," said Jason Spittle, global director of training at U.S. medical
device maker Cook Medical, which has a reproductive health unit.
"China is set to be the biggest
IVF market in the world, probably within the next couple of years."
Looking overseas
Chinese couples who have the
financial means often go abroad to the United States, Australia, Thailand and
Vietnam for IVF.
"The biggest driver is that
there are so many hoops to jump through to get IVF treatment here," said
Mr Lei, a China-based intermediary who helps patients go to Thailand, who like
many Chinese was reluctant to give his full name to a reporter.
Rising Chinese demand for fertility
treatments is therefore good news for overseas clinics such as Australia-based
Monash IVF Group and Virtus Health or Superior A.R.T. in Thailand, where 30-40
percent of patients come from China.
"Our clinic has prepared
Chinese-speaking staff to coordinate with rising number of Chinese
patients," said Superior A.R.T. deputy manager Arnon Sinsawasdi, adding
the end of the one-child policy should give business a boost.
Zuckerberg's paid
paternity plan
Facebook CEO Mark Zuckerberg plans to put the
trust in his team's hands immediately following the birth of his baby,
reports CNBC's Julia Boorstin.
IVF Australia, part of Virtus Health,
plays on Chinese demand for the latest procedures with a Chinese-language
website advertising its "cutting-edge technology" to help parents
"achieve their dream of having a child".
"Lots of patients go to these
places just because they have unique demands. For example domestically they
can't do things like surrogacy or gender selection," said Li Yuan,
director of reproductive medicine centre at Beijing Chaoyang Hospital.
Non-commercial surrogacy is allowed
in Australia, while the United States permits gender selection. Thailand,
though, has been cracking down on both practices to close loopholes that have
lured patients from overseas.
Overloaded clinics
Patients and doctors in China said
state IVF centres were often over-stretched - little surprise given each clinic
serves around 3.8 million people, compared with 700,000 people per clinic in
the United States, health ministry data show.
"Clinics are so busy it's
unbearable. Whichever hospital you go to it's always crammed with people,"
said a junior doctor at an IVF clinic in Shanghai, who asked not to be named.
This creates a market for unregulated
providers, who advertise their offerings online and on social media platforms,
while avoiding detection by overworked watchdogs despite a recent crackdown on
the market.
Why China's baby policy won't spur a boom
"In the past few years our
checks in some areas haven't been strict enough, routine oversight has been
lax, and strikes against illegal behaviour have fallen short," China's
health ministry said in a statement in July.
"That's led to chaos in the
assisted reproduction market."
Patient numbers are still climbing
too. There were nearly half a million treatment "cycles" in 2013 at
356 approved clinics, compared with just under 200,000 cycles that year in the
higher-value U.S. market.
Despite the growth, though, many
still struggle to get access to IVF at all: poorer provinces have few clinics
and many can't afford a pricetag that starts at 30,000 yuan ($4,697).
"You can't use state insurance,
it's all paid out-of-pocket," said Ms Cui, 37, a financial worker in
Dalian who underwent successful IVF treatment in 2013.
"I was lucky that it worked in
one go, but many people try a number of times which mean it's even more
expensive."